Streetbeat News

Products Services

OSS

OSS has introduced a new Gen 5 AI Transportable Compute Server, which is designed to deliver advanced computing capabilities for AI applications. This new product is likely to enhance OSS's offerings in the AI space and could attract attention from industries requiring high-performance, transportable computing solutions.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 1:32 pm

EVLV

Evolv Technology (NASDAQ:EVLV) announced significant milestones, having screened over 1 billion visitors with its AI-based weapons detection system, Evolv Express, since 2019. The company detected nearly 300,000 guns and knives in the first nine months of 2023 and now screens over 2 million people per day. Evolv has over 4,000 active long-term subscriptions and is stopping an average of 1,000 weapons daily. Customers like Niagara Falls City School District, Lincoln Center, and Boch Center praised Evolv's non-intrusive, comprehensive security solutions.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 1:22 pm

PANW

Palo Alto Networks (NASDAQ:PANW) has released Cortex XSIAM 2.0, an AI-driven security operations platform with a new bring-your-own machine learning (BYOML) framework. This allows customers to integrate their own ML models for unique use cases. The platform, which ingests over 5 petabytes of security data daily, also features a Command Center for improved incident monitoring and a MITRE ATT&CK Coverage Dashboard for assessing defense capabilities. XSIAM has led to significant improvements in incident resolution for companies like an oil and gas company, Boyne Resorts, and Imagination Technologies. The platform is now globally available.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 1:15 pm

ENPH

Enphase Energy, Inc. (NASDAQ:ENPH) has started shipping its most powerful microinverters, the IQ8P, in Brazil, designed to support high-powered solar modules with a peak output of 480 W. The launch follows the introduction of the Solargraf platform in Brazil, aiding solar installers in the sales and installation process. The IQ8P Microinverters can handle a continuous DC current of 14 Amperes and pair with solar modules up to 670 W DC. They come with a 25-year limited warranty and integrate with the Enphase Energy System and IQ Gateway for easy monitoring and updates via the Enphase App.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 1:13 pm

RPRX

TEVA

Teva Pharmaceutical Industries Ltd. and Royalty Pharma have announced a collaboration to accelerate the development of Olanzapine LAI, a long-acting injectable for schizophrenia treatment. Royalty Pharma will provide up to $125 million in R&D funding support for the program.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 1:12 pm

MBRX

Moleculin Biotech, Inc. has provided a preliminary update on its recent clinical activities and outlined expected near-term milestones for its clinical development pipeline. The update includes progress on various clinical trials and anticipated key events that could influence the company's future direction and investor sentiment.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 1:06 pm

ALGS

Aligos Therapeutics presented clinical and nonclinical data at the AASLD Liver Meeting 2023, showing that its drug ALG-055009 has a favorable risk-benefit profile. This could potentially impact the company's stock as investors react to the positive news regarding the drug's development.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 1:05 pm

DXR

Daxor Corporation has announced the presentation of data from a Phase I NIH-sponsored trial at the American Heart Association Annual Meeting. The data is likely to be significant for the company's profile in the medical community and could influence investor perception.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 1:03 pm

IPA

ImmunoPrecise's subsidiary BioStrand has published a preprint of its white paper on Biorxiv.org, titled 'New Paradigm For Biological Sequence Retrieval Inspired By Natural Language Processing And Database Research'.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 1:01 pm

MDGS

Medigus' subsidiary, Metagramm, is set to develop Bubbl, an AI-powered writing and grammar tool. This move signals Medigus' entry into the AI-driven content creation market, potentially expanding its product offerings and market reach.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 12:56 pm